Search the webpage

Director In Vivo Pharmacology. Location: Headquarters, Kuopio, Finland.

Director In Vivo Pharmacology. Location: Headquarters, Kuopio, Finland.

ABOUT

Dr. Cerrada-Gimenez obtained his PhD in Biotechnology from the A.I. Virtanen Institute at the University of Eastern Finland in 2011. Shortly thereafter, Marc joined Charles River Discovery Services (Kuopio, Finland), where he led the Biomarker and in vitro team designing and leading multiple projects, which aimed at studying various neurodegenerative indications.

In 2016, he joined the biotech Minoryx Therapeutics as Head of Biomarker Discovery collaborating in the development of compounds for the treatment of rare diseases, with the most advanced candidate currently undergoing Phase II-III. During that time he acquired experience in the preparation and submission of regulatory documents for the EMA and FDA.

FOLLOW

CONTACT ME BY EMAIL

Marc Gimenez

LATEST NEWS

Experimentica Ltd. participates in ORBITAL, an EU Horizon 2020 Marie Sklodowska-Curie Innovative Training Network award

News
Experimentica Ltd. is pleased to announce its participation as beneficiary in EU Horizon 2020 Marie Sklodowska-Curie Innovative Training Network award ... Read More

A retinal organotypic model for ex vivo neuroprotection studies

News
A recently published study by Experimentica Ltd. and its collaborators from the University of Tampere, Finland, shows that when the ... Read More

Thank you for visiting us at ARVO 2019 conference

News
Created by Simon Kaja on   June 5, 2019   in category: News Thank you, everyone, for visiting our booth at ARVO 2019 in Vancouver, Canada, ... Read More

Subscribe to Our Newsletter!

We promise that no sales pitches will be attached to newsletter. And don't worry, we hate spammers too!